JVA vs MED
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 11, 2026
JVA
MED
Investment Advisor Scores
MED
AI Analyst Insights
Detailed Metrics Comparison
| Metric | JVA | MED | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 13.3869 | 12.4844 | MED |
| PEG Ratio | 0.893 | 0.972 | JVA |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -9.3% | -19.4% | JVA |
| Earnings Growth | -59.2% | -87.2% | JVA |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 35.0/100 | 39.2/100 | MED |
| Profit Margin | 4.9% | -13.6% | JVA |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | AVOID NEW MONEY | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
JVA
MarkupPrice above SMA50, rising 50-day trend (14.4% over 20 days), RSI 65
MED
MarkupPrice above SMA50, rising 50-day trend (1.9% over 20 days), RSI 57
Fundamentals Snapshot
| Metric | JVA | MED |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 13.4 | -321.5 |
| Trailing P/E | 6.0 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.1% | -0.2% |
| Gross Margin | 0.2% | 0.7% |
| Operating Margin | 0.1% | -0.1% |
| EPS | 0.83 | -3.70 |
| Dividend Yield | 0.02% | — |